Type
|
Public |
---|---|
Traded as | NYSE: AXLL |
Industry | Chemical |
Predecessor | Georgia Gulf Corporation |
Founded | 2013 |
Headquarters | Atlanta, Georgia, USA |
Revenue | US$ 2.8 billion (2010) |
Number of employees
|
6,214 (2007) |
Website | www.axiall.com |
The Axiall Corporation has historically been a major manufacturer and marketer of chlorovinyls (caustic soda, chlorine, VCM, EDC, PVC resins, PVC rigid and flexible compounds) and aromatics (acetone, cumene, phenol). With the acquisition of Royal Group Technologies the company is now also a major producer of building materials ranging from piping and siding to window profiles, decking, and fencing.
The company operates 47 locations in numerous states such as Mississippi, Louisiana, Oklahoma, Michigan, Tennessee, and Texas, and is headquartered in Atlanta, Georgia. As of November, 2007 the company employed 6,214 full-time individuals.
The Georgia Gulf Corp. became the Axiall Corp. with the completion of its $2 billion acquisition of PPG Industries Inc.'s chlor-alkali and derivatives business in 2013.
In 2014, Axiall entered a joint venture with Shriram Polytech India, forming Shriram Axiall. The two companies partnered together "to provide a technological thrust to the PVC offering for different industries".
Aug. 31, 2016—Westlake Chemical Corporation (NYSE:WLK) announced that it has completed the $3.8 billion acquisition of Axiall Corporation (NYSE: AXLL). The combined company will be the third-largest chlor-alkali producer and the second-largest polyvinyl chloride (PVC) producer in North America.
2016-07-11 | Reiterated Rating | Nomura Holdings Inc. | Hold | |
2016-06-13 | Boost Price Target | Citigroup Inc. | Neutral | $23.35 to $33.00 |
2016-06-13 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $26.50 to $33.00 |
2016-06-01 | Lower Price Target | Cowen and Company | Market Perform | $29.00 to $17.00 |
2016-05-05 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $25.00 |
2016-04-06 | Reiterated Rating | Citigroup Inc. | Hold | $23.40 |
2016-04-04 | Downgrade | SunTrust | Buy to Neutral | |
2016-04-04 | Downgrade | SunTrust Banks Inc. | Buy to Neutral | |
2016-03-10 | Upgrade | Cowen and Company | Market Perform to Outperform | $17.00 to $25.00 |
2016-02-26 | Boost Price Target | Nomura | Neutral | $17.00 to $20.00 |
2016-02-26 | Boost Price Target | Nomura Holdings Inc. | Neutral | $17.00 to $20.00 |
2016-02-08 | Boost Price Target | RBC Capital | Sector Perform | $11.00 to $20.00 |
2016-02-08 | Boost Price Target | Royal Bank Of Canada | Sector Perform | $11.00 to $20.00 |
2016-02-01 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $25.00 |
2016-02-01 | Downgrade | Citigroup Inc. | Buy to Neutral | $19.00 |
2016-01-29 | Downgrade | Wells Fargo | Outperform to Market Perform | |
2016-01-29 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
2016-01-13 | Lower Price Target | Nomura | $20.00 to $17.00 | |
2016-01-06 | Lower Price Target | Cowen and Company | Market Perform | $29.00 to $17.00 |
2016-01-05 | Lower Price Target | Citigroup Inc. | $24.00 to $19.00 | |
2015-11-04 | Boost Price Target | Nomura | Neutral | $19.00 to $20.00 |
2015-11-04 | Boost Price Target | RBC Capital | Sector Perform | $18.00 to $22.00 |
2015-10-05 | Lower Price Target | RBC Capital | Sector Perform | $32.00 to $18.00 |
2015-09-29 | Boost Price Target | Nomura | Neutral | $19.00 |
2015-08-24 | Reiterated Rating | Cowen and Company | Hold | |
2015-08-21 | Lower Price Target | Cowen and Company | Market Perform | $37.00 to $29.00 |
2015-08-10 | Reiterated Rating | JPMorgan Chase & Co. | Hold | $28.00 |
2015-08-07 | Reiterated Rating | Citigroup Inc. | Buy | $40.00 to $37.00 |
2015-08-07 | Lower Price Target | RBC Capital | Sector Perform | $34.00 to $32.00 |
2015-07-24 | Initiated Coverage | Nomura | Neutral | $35.00 |
2015-07-08 | Reiterated Rating | Cowen and Company | Market Perform | $39.00 to $37.00 |
2015-06-17 | Reiterated Rating | Cowen and Company | Market Perform | $39.00 |
2015-06-11 | Upgrade | SunTrust | Neutral to Buy | $44.00 |
2015-05-27 | Lower Price Target | Cowen and Company | Market Perform | $48.00 to $39.00 |
2015-05-26 | Lower Price Target | JPMorgan Chase & Co. | Neutral | $44.00 to $36.00 |
2015-05-17 | Reiterated Rating | RBC Capital | Hold | $39.00 |
2015-05-07 | Lower Price Target | RBC Capital | Sector Perform | $48.00 to $39.00 |
2015-04-30 | Upgrade | Citigroup Inc. | Neutral to Buy | $49.00 to $49.00 |
2015-03-10 | Reiterated Rating | Cowen and Company | Hold | $45.00 to $48.00 |
2015-02-25 | Upgrade | RBC Capital | Underperform to Sector Perform | |
2015-02-23 | Reiterated Rating | Citigroup Inc. | Hold | $44.00 to $49.00 |
2014-11-06 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $37.00 to $36.00 |
2014-11-06 | Boost Price Target | RBC Capital | Underperform | $28.00 to $32.00 |
2014-10-23 | Downgrade | Cowen and Company | Outperform to Market Perform | $50.00 to $45.00 |
2014-10-08 | Initiated Coverage | RBC Capital | Underperform | $28.00 |
2014-10-06 | Reiterated Rating | Citigroup Inc. | Neutral | $41.00 to $39.00 |
2014-09-24 | Reiterated Rating | Citigroup Inc. | Neutral | $46.00 to $41.00 |
2014-07-10 | Reiterated Rating | Citigroup Inc. | Neutral | $49.00 to $48.00 |
2014-06-24 | Reiterated Rating | Cowen and Company | Outperform | |
2014-05-07 | Reiterated Rating | Citigroup Inc. | Hold | $51.00 to $49.00 |
2014-05-07 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $41.00 to $45.00 |
2014-04-09 | Boost Price Target | Citigroup Inc. | Neutral | $48.00 to $51.00 |
2014-04-08 | Boost Price Target | Goldman Sachs | $66.00 | |
2014-03-24 | Upgrade | Bank of America | Neutral to Buy | $50.00 to $52.00 |
2014-03-06 | Upgrade | Goldman Sachs | Neutral to Buy | $45.00 to $60.00 |
2014-02-21 | Reiterated Rating | Citigroup Inc. | Neutral | $51.00 to $48.00 |
2013-10-30 | Downgrade | Citigroup Inc. | Buy to Neutral | $46.00 to $43.00 |
2013-10-09 | Reiterated Rating | Wells Fargo & Co. | Outperform | $50.00 |
2013-10-09 | Reiterated Rating | Wells Fargo | Outperform | $50.00 |
2013-07-17 | Reiterated | Cowen | Outperform | $64 to $58 |
2013-05-09 | Reiterated | UBS | Neutral | $56 to $53 |
2016-07-11 | Reiterated Rating | Nomura Holdings Inc. | Hold | |
2016-06-13 | Boost Price Target | Citigroup Inc. | Neutral | $23.35 to $33.00 |
2016-06-13 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $26.50 to $33.00 |
2016-06-01 | Lower Price Target | Cowen and Company | Market Perform | $29.00 to $17.00 |
2016-05-05 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $25.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AXLL 5 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
RUSSELL FRANK CO/ | 0.85M |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 0.39M |
FORT PITT CAPITAL GROUP INC | 0.25M |
MANAGED ACCOUNT ADVISORS LLC | 37688 |
Placemark Investments, Inc. | 10973 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Carrico Paul President & CEO | 0.45% (313734) | AXLL / GPK / |
THOMPSON GREGORY C Chief Financial Officer | 0.33% (229149) | AXLL / CRRC / |
Mann Timothy JR EVP, Gen. Counsel & Secretary | 0.21% (144601) | AXLL / LPX / |
Orcutt Mark James Executive VP, Bldg Products | 0.17% (117181) | AXLL / |
Breunig Joseph C. Exec. VP, Chemicals | 0.12% (81381) | AXLL / MTX / |
Bates Simon Sr. VP, Building Products | 0.10% (72298) | AXLL / |
James Worrell Vice President, Human Resouces | 0.10% (70413) | AXLL / |
Adelman Dean A VP, Human Resources | 0.06% (44013) | AXLL / BXC / |
Fishbein Daniel S. VP and General Counsel | 0.06% (41721) | AXLL / |
DOHERTY WILLIAM H Sr. Vice President Chemicals | 0.04% (31019) | AXLL / |
Noetzel Mark L | 0.03% (23439) | AXLL / |
Gervis Robert M. | 0.03% (23439) | AXLL / |
WEINSTEIN DAVID N | 0.03% (23439) | AXLL / SGY / |
DENICOLA T KEVIN | 0.03% (23439) | AXLL / CMA / |
Piciacchio Sharon Sr. Vice President Procurement | 0.02% (16959) | AXLL / |
FLEMING PATRICK J | 0.02% (16371) | AXLL / |
Macadam Stephen E. | 0.02% (15795) | AXLL / NPO / VVV / |
Biltz George Chief Strategy Officer | 0.02% (14775) | AXLL / |
MCGARRY MICHAEL H | 0.02% (13907) | AXLL / PPG / |
SALES WAYNE C | 0.02% (12742) | AXLL / SVU / |
HAYNES VICTORIA F | 0.02% (11627) | AXLL / NUE / PPG / |
MANSFIELD WILLIAM L | 0.01% (8644) | AXLL / BMS / TGI / |
RIPP ROBERT | 0.01% (8212) | AXLL / LPTH / PPG / |